The Europe Hernia Mesh Devices Market would witness market growth of 6.5% CAGR during the forecast period (2023-2030). In the year 2020, the Europe market's volume surged to 3,852.6 thousand units, showcasing a growth of 6.3% (2019-2022).
Hernia mesh devices have lower hernia recurrence rates than non-mesh repairs. This lower recurrence rate contributes to increased patient satisfaction and a lower burden on healthcare systems. Hernia mesh devices provide structural reinforcement to the weakened abdominal wall, reducing the likelihood of complications and enhancing patient outcomes. These devices have become an essential component of modern hernia surgery. As surgeons gain experience with mesh implantation techniques, they are more likely to incorporate hernia mesh devices into their practice. This trend is driving increased adoption rates as medical professionals recognize the benefits of these devices.
With medical imaging and technology advancements, personalized hernia care is becoming a reality. Surgeons can tailor their approach to each patient's unique needs, selecting the most appropriate hernia mesh device and surgical technique. The development of biocompatible materials for hernia mesh devices is a significant trend. These materials reduce the risk of complications and adverse reactions, making hernia mesh surgery safer and more effective. Innovations in mesh fixation techniques are improving patient outcomes. Hernia mesh devices are now designed with features like self-gripping properties, reducing the need for additional fixation devices and simplifying the surgical process. The integration of robotic-assisted surgical systems is revolutionizing hernia repair. Robots offer greater precision and control to surgeons, resulting in minimally invasive procedures with reduced postoperative pain and quicker recovery times.
According to a report on the French aging policy published by the UN, as in other European countries, France faces a continuous and significant increase in older adults: in 2012, there were 15 million people aged more than 60 years old in France. This number will reach to 24 million in 2060. As the aging population grows in France, there is an increased prevalence of hernias, including inguinal, incisional, and femoral hernias. This drives the demand for hernia repair procedures and mesh devices. The aging demographic increases the demand for hernia repair procedures in France. Due to these aspects, the market will grow across Europe in the upcoming years.
The Germany market dominated the Europe Hernia Mesh Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $467.8 Million by 2030. The UK market is experiencing a CAGR of 5.5% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 7.3% during (2023 - 2030).
Based on Type, the market is segmented into Synthetic and Biologic. Based on Hernia Type, the market is segmented into Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton Dickinson and Company, Johnson & Johnson, W. L. Gore & Associates, Inc., Atrium Medical Corporation (Getinge AB), B. Braun Melsungen AG, Baxter International, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Integra LifeSciences Holdings Corporation, and Herniamesh S.r.l.
Hernia mesh devices have lower hernia recurrence rates than non-mesh repairs. This lower recurrence rate contributes to increased patient satisfaction and a lower burden on healthcare systems. Hernia mesh devices provide structural reinforcement to the weakened abdominal wall, reducing the likelihood of complications and enhancing patient outcomes. These devices have become an essential component of modern hernia surgery. As surgeons gain experience with mesh implantation techniques, they are more likely to incorporate hernia mesh devices into their practice. This trend is driving increased adoption rates as medical professionals recognize the benefits of these devices.
With medical imaging and technology advancements, personalized hernia care is becoming a reality. Surgeons can tailor their approach to each patient's unique needs, selecting the most appropriate hernia mesh device and surgical technique. The development of biocompatible materials for hernia mesh devices is a significant trend. These materials reduce the risk of complications and adverse reactions, making hernia mesh surgery safer and more effective. Innovations in mesh fixation techniques are improving patient outcomes. Hernia mesh devices are now designed with features like self-gripping properties, reducing the need for additional fixation devices and simplifying the surgical process. The integration of robotic-assisted surgical systems is revolutionizing hernia repair. Robots offer greater precision and control to surgeons, resulting in minimally invasive procedures with reduced postoperative pain and quicker recovery times.
According to a report on the French aging policy published by the UN, as in other European countries, France faces a continuous and significant increase in older adults: in 2012, there were 15 million people aged more than 60 years old in France. This number will reach to 24 million in 2060. As the aging population grows in France, there is an increased prevalence of hernias, including inguinal, incisional, and femoral hernias. This drives the demand for hernia repair procedures and mesh devices. The aging demographic increases the demand for hernia repair procedures in France. Due to these aspects, the market will grow across Europe in the upcoming years.
The Germany market dominated the Europe Hernia Mesh Devices Market by Country in 2022, and would continue to be a dominant market till 2030; thereby, achieving a market value of $467.8 Million by 2030. The UK market is experiencing a CAGR of 5.5% during (2023 - 2030). Additionally, The France market would exhibit a CAGR of 7.3% during (2023 - 2030).
Based on Type, the market is segmented into Synthetic and Biologic. Based on Hernia Type, the market is segmented into Inguinal Hernia, Incisional Hernia, Femoral Hernia, and Others. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Becton Dickinson and Company, Johnson & Johnson, W. L. Gore & Associates, Inc., Atrium Medical Corporation (Getinge AB), B. Braun Melsungen AG, Baxter International, Inc., Cook Medical, Inc. (Cook Group), Medtronic PLC, Integra LifeSciences Holdings Corporation, and Herniamesh S.r.l.
Scope of the Study
Market Segments Covered in the Report:
By Type (Volume, thousand units, USD Million, 2019-2030)- Synthetic
- Biologic
- Inguinal Hernia
- Incisional Hernia
- Femoral Hernia
- Others
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
- Becton Dickinson and Company
- Johnson & Johnson
- W.L. Gore & Associates, Inc.
- Atrium Medical Corporation (Getinge AB)
- B.Braun Melsungen AG
- Baxter International, Inc.
- Cook Medical, Inc. (Cook Group)
- Medtronic PLC
- Integra LifeSciences Holdings Corporation
- Herniamesh S.r.l.
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology
Chapter 2. Market at a Glance
Chapter 3. Market Overview
Chapter 4. Europe Hernia Mesh Devices Market by Type
Chapter 5. Europe Hernia Mesh Devices Market by Hernia Type
Chapter 6. Europe Hernia Mesh Devices Market by Country
Chapter 7. Company Profiles
Companies Mentioned
- Becton Dickinson and Company
- Johnson & Johnson
- W. L. Gore & Associates, Inc.
- Atrium Medical Corporation (Getinge AB)
- B. Braun Melsungen AG
- Baxter International, Inc.
- Cook Medical, Inc. (Cook Group)
- Medtronic PLC
- Integra LifeSciences Holdings Corporation
- Herniamesh S.r.l.
Methodology
LOADING...
